StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Threshold Pharmaceuticals, Inc.

Enter Symbol or Keywords

OPS Ranking of "8" for Threshold Pharmaceuticals Reiterated by StockDiagnostics.com

Stock Quote: (NCM:THLD)

11/17/2009

1.75

0.00

0.00%

1,000

OPS Ranking of "8" for Threshold Pharmaceuticals Reiterated by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 17, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "8" for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD). Threshold Pharmaceuticals has had an OP ... read full story

Website Address:	www.thresholdpharm.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: THLD

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: THLD

11/19/2009

Threshold Pharmaceuticals' EBITDA Deteriorates 14.3%

11/17/2009

Threshold Pharmaceuticals Experiencing Revenue Downtrend While its Industry is in an Uptrend

11/17/2009

OPS Ranking of "8" for Threshold Pharmaceuticals Reiterated by StockDiagnostics.com

... more THLD exclusives

Other News Sources: THLD

01/25/2010

Threshold Presents Clinical Trial Data From a Phase 1/2 Clinical Trial of TH-302 at ASCO Gastrointestinal Conference

01/12/2010

Threshold Pharmaceuticals Provides Clinical Development Update at J.P. Morgan Healthcare Conference

01/05/2010

Threshold to Present at J.P. Morgan Healthcare Conference

... more THLD news from other sources

Daily Market Updates

02/10/2010

Futures Flat After December Trade Deficit Widens to $40.2 Billion

Futures fell off their highs in the premarket after the December trade deficit was reported to have widened to $40.2 billion from $36.4 billion in November on a sharp gain in imports. That was much higher than the expected deficit of $36.8 billion. F ... read full story